Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. White, Wanjie Sun, P. Cleary, R. Danis, M. Davis, D. Hainsworth, L. Hubbard, J. Lachin, D. Nathan (2008)
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.Archives of ophthalmology, 126 12
Catherine Martin, J. Albers, W. Herman, P. Cleary, B. Waberski, D. Greene, M. Stevens, E. Feldman (2006)
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.Diabetes care, 29 2
R. Engerman, T. Kern (1995)
Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.Archives of ophthalmology, 113 3
Sayon Roy, Roberto Sala, Enrico Cagliero, Mara Lorenzi (1990)
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.Proceedings of the National Academy of Sciences of the United States of America, 87 1
H Al-Kateb, L Mirea, X Xie (2007)
Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study., 56
S. Genuth, Wanjie Sun, P. Cleary, D. Sell, W. Dahms, J. Malone, W. Sivitz, V. Monnier (2005)
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.Diabetes, 54 11
E. Seaquist, F. Goetz, S. Rich, J. Barbosa (1989)
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.The New England journal of medicine, 320 18
(2008)
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes: 10 years after the DCCT., 126
FI Caird, A Pirie, TG Ramsell
Diabetes and the Eye.
(2003)
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study., 290
H. Al‐Kateb, L. Mirea, Xinlei Xie, Lei Sun, Michelle Liu, Hongtao Chen, S. Bull, A. Boright, A. Paterson (2007)
Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 DiabetesDiabetes, 56
H Al-Kateb, AP Boright, L Mirea (2008)
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study., 57
Z. Tong, Zhenglin Yang, Shrena Patel, H. Chen, D. Gibbs, Xian Yang, V. Hau, Y. Kaminoh, J. Harmon, E. Pearson, J. Buehler, Yuhong Chen, Baifeng Yu, N. Tinkham, N. Zabriskie, Jiexi Zeng, Ling Luo, Jennifer Sun, M. Prakash, R. Hamam, S. Tonna, R. Constantine, Cecinio Ronquillo, S. Sadda, R. Avery, John Brand, N. London, A. Anduze, G. King, P. Bernstein, Scott Watkins, L. Jorde, Dean Li, L. Aiello, M. Pollak, Kang Zhang (2008)
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complicationsProceedings of the National Academy of Sciences, 105
H. Al‐Kateb, A. Boright, L. Mirea, Xinlei Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, Michelle Liu, J. Bucksa, V. Arends, M. Steffes, P. Cleary, Wanjie Sun, J. Lachin, P. Thorner, Michael Ho, A. McKnight, A. Maxwell, D. Savage, K. Kidd, J. Kidd, W. Speed, T. Orchard, Rachel Miller, Lei Sun, S. Bull, A. Paterson (2008)
Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic NephropathyDiabetes, 57
R. Engerman, T. Kern (1987)
Progression of Incipient Diabetic Retinopathy During Good Glycemic ControlDiabetes, 36
(1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)., 352
R. Turner, C. Fox, Matthews, H. Mcelroy, C. Cull, R. Holman, P. Neil, D. Hadden, D. Wright, É. Manley, I. Stratton, Uk Diabetes, E. Kohner, Frighi, Michael Gnant (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.The Lancet
R. Klein, B. Klein, S. Moss, M. Davis, D. DeMets (1984)
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.Archives of ophthalmology, 102 4
Diabetes Control, D. Nathan, S. Genuth, J. Lachin, P. Cleary, O. Crofford, M. Davis, L. Rand, C. Siebert (1993)
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.The New England journal of medicine, 329 14
S. Genuth, Janie Lipps, G. Lorenzi, D. Nathan, M. Davis, J. Lachin, P. Cleary (2002)
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.JAMA, 287 19
(1997)
Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial., 46
RG Nelson, WC Knowler, DJ Pettitt, PH Bennett
Kidney diseases in diabetes.
EDITORIAL Metabolic Memory in Diabetes Is True Long-term Memory N 1993, THE DIABETES CONTROL AND COMPLI- lactosemic dogs, which develop a retinopathy that is simi- cations Trial’s (DCCT’s) demonstration that strict lar in many respects to nonproliferative diabetic reti- control of blood glucose to near-normal levels nopathy in humans (pericyte loss, microaneurysms, and during an average of 6.5 years in subjects with acellular capillaries). Much earlier, Caird et al made the I type 1 diabetes significantly reduced the pro- astute observation that their young diabetic patients who gression of retinopathy as well as other chronic micro- maintained good control of their blood glucose during vascular complications of the disease was among the most the first 5 years of their diabetes seemed to be protected important results from a randomized controlled clinical from the later development of severe retinopathy. In 1990, 1 10 trial in medical history. This was followed, a few years Roy and his collaborators reported increased fibronec- later, by the results of another randomized controlled trial, tin messenger RNA levels, which persisted long after the the United Kingdom Prospective Diabetes Study, which restoration of near normoglycemia, in the kidney cortex demonstrated the same result for subjects with
JAMA Ophthalmology – American Medical Association
Published: Mar 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.